Call Options Transactions Made in Q2 2024 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q2 2024. The information is specifically focused on institutions that hold call options of ARROWHEAD PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Artal Group S.A.
Luxembourg, N4 |
BUY
|
CALL |
400K+ 66.67% |
$8.75M - $11.3M
|
1M
$21.1M
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
39.8K+ 25.03% |
$870K - $1.12M
|
199K
$4.18M
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
25.6K+ 123.67% |
$560K - $723K
|
46.3K
$975K
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
BUY
|
CALL |
21.2K+ 85.14% |
$464K - $599K
|
46.1K
$970K
|
|
Aug 14, 2024
Q2 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
14.6KNew |
$319K - $412K
|
14.6K
$307K
|
|
Aug 14, 2024
Q2 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
11.3KNew |
$247K - $319K
|
11.3K
$238K
|
|
Aug 14, 2024
Q2 2024
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-8.5K- 52.47% |
$186K - $240K
|
7.7K
$162K
|